Correlation Between Replimune and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Replimune and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Cullinan Oncology LLC, you can compare the effects of market volatilities on Replimune and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Cullinan Oncology.
Diversification Opportunities for Replimune and Cullinan Oncology
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Replimune and Cullinan is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Replimune i.e., Replimune and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Replimune and Cullinan Oncology
Given the investment horizon of 90 days Replimune Group is expected to generate 1.58 times more return on investment than Cullinan Oncology. However, Replimune is 1.58 times more volatile than Cullinan Oncology LLC. It trades about 0.09 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.13 per unit of risk. If you would invest 1,037 in Replimune Group on September 6, 2024 and sell it today you would earn a total of 280.00 from holding Replimune Group or generate 27.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.44% |
Values | Daily Returns |
Replimune Group vs. Cullinan Oncology LLC
Performance |
Timeline |
Replimune Group |
Cullinan Oncology LLC |
Replimune and Cullinan Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Replimune and Cullinan Oncology
The main advantage of trading using opposite Replimune and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |